@CathyJoeGPT@lrozen Why? Don’t you understand the financial/access incentives? Operation Mockingbird? Lots of systemic structures support the exhibited behavior.
Scientists say clinical trials for ‘variant-proof’ vaccines could start very soon https://t.co/pFQqmuIzQv: E or M proteins could be part of the solution, but agree that nucleocapsid [N] + spike [S] has the most promise for next-gen vaccines
Look forward to discussing what’s possible in massive plant-based #vaccine manufacturing and its two vaccine candidates with #iBio CEO Tom Isett on today’s #coronavirus report from @thehill. #COVID19#innovation https://t.co/dj4RfVeE3V
My contribution to #FunFactFriday - human Mesenchymal #StemCells from bone marrow share material from inside themselves (protein, RNA) with damaged target cells through microparticles, exosomes, and tunneling nanotubules. It's called Cell-to-Cell communication. We love science!
Michael Kalos (Jassen) - J&J is planning to build wholly owned centralized CAR-T manufacturing plants around the world, following $NVS and $GILD model https://t.co/5AhBzt3DWD